Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102350![]() (US10562854, No. F3 | US8536181, F3 | US9278930, F3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102349![]() (US10562854, No. E33 | US8536181, E33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102345![]() (US10562854, No. D10 | US8536181, D10 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102351![]() (US10562854, No. F2 | US8536181, F2 | US9278930, F2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102350![]() (US10562854, No. F3 | US8536181, F3 | US9278930, F3) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102339![]() (US8536181, B5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102336![]() (US10562854, No. C17 | US8536181, C17 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102341![]() (US10562854, No. B14 | US8536181, B14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102342![]() (US10562854, No. C19 | US8536181, C19 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102337![]() (US10562854, No. C35 | US8536181, C35 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102338![]() (US10562854, No. C14 | US8536181, C14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102346![]() (US10562854, No. D14 | US8536181, D14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102347![]() (US10562854, No. C1 | US8536181, C1 | US9278930, C1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102343![]() (US10562854, No. B9 | US8536181, B9 | US9278930, B9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.26E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102348![]() (US10562854, No. A41 | US8536181, A41 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102340![]() (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102348![]() (US10562854, No. A41 | US8536181, A41 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | 1.66E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102343![]() (US10562854, No. B9 | US8536181, B9 | US9278930, B9) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102344![]() (US10562854, No. A18 | US8536181, A18 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102346![]() (US10562854, No. D14 | US8536181, D14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102338![]() (US10562854, No. C14 | US8536181, C14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.06E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Egl nine homolog 1 (Homo sapiens (Human)) | BDBM102349![]() (US10562854, No. E33 | US8536181, E33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description EGLN enzyme activity assay is determined using mass spectrometry (matrix-assisted laser desorption ionization, time-of-flight MS, MALDI-TOF MS. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102345![]() (US10562854, No. D10 | US8536181, D10 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102336![]() (US10562854, No. C17 | US8536181, C17 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.74E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102344![]() (US10562854, No. A18 | US8536181, A18 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.92E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102347![]() (US10562854, No. C1 | US8536181, C1 | US9278930, C1) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102337![]() (US10562854, No. C35 | US8536181, C35 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.25E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102339![]() (US8536181, B5) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102340![]() (US10562854, No. C33 | US8536181, C33 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.30E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102342![]() (US10562854, No. C19 | US8536181, C19 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.29E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102341![]() (US10562854, No. B14 | US8536181, B14 | US9278930, ...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Vascular endothelial growth factor A (Homo sapiens (Human)) | BDBM102351![]() (US10562854, No. F2 | US8536181, F2 | US9278930, F2) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Aerpio Therapeutics Inc. US Patent | Assay Description ELISA assay using VEGF. | US Patent US8536181 (2013) BindingDB Entry DOI: 10.7270/Q2D21W79 | |||||||||||
More data for this Ligand-Target Pair |